We are live on !
Find out more
Jackson Square Capital Portfolio holdings
AUM
$667M
Turnover
24.84%
1-Year Est. Return
118.76%
This Fund
S&P 500
This Quarter Est. Return
+1.63%
1 Year Est. Return
+118.76%
3 Year Est. Return
+422.74%
5 Year Est. Return
+611.2%
10 Year Est. Return
–
AUM
$667M
AUM Growth
-$51.7M
(-7.2%)
Cap. Flow
-$29.8M
Cap. Flow % of AUM
Cap. Flow %
-4.47%
Top 10 Holdings %
Top 10 Hldgs %
49.72%
Holding
161
New
23
Increased
48
Reduced
43
Closed
17
Avg Time Held
Equity + Options
2.7
years
Top 10 Avg Time Held
Equity + Options
2.6
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
2.7
years
Top 10 Avg Time Held Equity only
2.6
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$6.36M |
| 2 |
Amphenol
APH
|
+$5.72M |
| 3 |
SPDR Gold Trust
GLD
|
+$4.29M |
| 4 |
Danaher
DHR
|
+$4.05M |
| 5 |
Microsoft
MSFT
|
+$3.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$11.5M |
| 2 |
Howmet Aerospace
HWM
|
+$8.01M |
| 3 |
Linde
LIN
|
+$7.3M |
| 4 |
Corning
GLW
|
+$7.21M |
| 5 |
TJX Companies
TJX
|
+$7.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 63.1% |
| 2 | Healthcare | 9.76% |
| 3 | Communication Services | 6.42% |
| 4 | Industrials | 5.78% |
| 5 | Miscellaneous | 5.56% |
Similar funds
CM
Jackson Square Capital's Q3 2026 Portfolio in Review
As of Q3 2026, Jackson Square Capital held 161 positions worth $667M, down 7.2% from $719M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Jackson Square Capital withdrew a net $29.8M in Q3 2026, closing 17 positions and reducing 43 holdings. Its most notable exit was Howmet Aerospace, an estimated $8.01M position sold in full.
By sector, the portfolio is most concentrated in Technology at 63% of assets, up from 63% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Jackson Square Capital opened a new position in AstraZeneca worth $6.22M.
- Jackson Square Capital's largest Q3 2026 buy was AstraZeneca: 38,184 shares worth $6.22M.
- Jackson Square Capital added most to Amphenol in Q3 2026, an estimated $5.72M increase.
- Jackson Square Capital's biggest Q3 2026 reduction was Micron Technology, cutting an estimated $11.5M.
- Jackson Square Capital fully exited Howmet Aerospace in Q3 2026, selling an estimated $8.01M.
- Jackson Square Capital's ten largest holdings make up 50% of its $667M portfolio in Q3 2026.
- Jackson Square Capital opened 23 new positions and closed 17 in Q3 2026.
- Jackson Square Capital's portfolio value fell 7.2% quarter-over-quarter to $667M.
Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.